Adaptimmune Therapeutics

www.adaptimmune.com
351 Rouse Boulevard
Philadelphia, PA 19112

Company Info

Phone
(215) 825-9260

Year Established
1999

Contacts

Adrian Rawcliffe
CEO

William Bertrand
COO

Elliot Norry, MD
CMO

Gavin Wood
CFO

Helen Tayton-Martin, Ph.D., M.B.A.
CBO

Joanna (Jo) Brewer
CSO

Kerry Sharp
General Counsel

Cintia Piccina
CCO

Company Description

Adaptimmune, formerly TCR2 Therapeutics, is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer.